Less Is More: The Power of Consolidation & Shared Governance in Health Tech Optimization

To avoid adding to the patchwork of disparate systems, healthcare leaders must balance their workforce’s eagerness to adopt new technologies with a focus on the consolidation of the right solutions. Here’s where to begin.  The post Less Is More: The Power of Consolidation & Shared Governance in Health Tech Optimization appeared first on MedCity News.

How Did Provider Groups React to Congress’ End-of-Year Healthcare Package?

Congress released a stopgap funding bill with a significant healthcare package, and provider groups are reacting favorably. They are mainly applauding provisions that reign in PBMs’ business practices, extend telehealth flexibilities, and boost payments to hospitals and physicians. The post How Did Provider Groups React to Congress’ End-of-Year Healthcare Package? appeared first on MedCity News.

Startup SiteOne Secures $100M to Forge Ahead With Novel Non-Opioid Pain Meds

SiteOne Therapeutics develops drugs that target sodium channels, the “wiring” in the body that transmits pain signals. Because SiteOne’s targets are located in the peripheral nervous system, they should not pose the same addiction risks as opioids, which hit receptors in the central nervous system. The post Startup SiteOne Secures $100M to Forge Ahead With…

The AI Advantage: Reimagining the Future of Drug Development 

Like any other tool, understanding the right problem to apply it to is the difference between success and failure. Addressing a problem is never just about technology; it’s always about people, processes, and technology.  The post The AI Advantage: Reimagining the Future of Drug Development  appeared first on MedCity News.

FDA Clears Withings’ New Blood Pressure Monitor That Allows Providers to Communicate Directly with Patients

This week, the FDA granted clearance to Withings’ BPM Pro 2 cellular blood pressure monitor. The device seeks to help providers scale remote patient monitoring for heart failure patients. The post FDA Clears Withings’ New Blood Pressure Monitor That Allows Providers to Communicate Directly with Patients appeared first on MedCity News.

Teva and Sanofi Mid-Stage Data Reveal Shows Best-in-Class Potential for IBD Drug

The Teva Pharmaceuticals and Sanofi drug, duvakitug, showed statistically significant and clinically meaningful results in a Phase 2b study in ulcerative colitis and Crohn’s disease. The drug is part of an emerging class of therapies that target TL1A, a protein involved in signaling that drives inflammation. The post Teva and Sanofi Mid-Stage Data Reveal Shows…